Literature DB >> 1347569

Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors.

B L Roth1, R D Ciaranello, H Y Meltzer.   

Abstract

We determined the affinities of clozapine and 21 other typical and atypical antipsychotic agents for the cloned 5-hydroxytryptamine-1C (5-HT1C) receptor. For these studies, 5-HT1C receptors were transiently expressed in COS-7 cells using the vector pSVK3-5HT1C. We discovered that clozapine and several other putative typical and atypical antipsychotic agents (loxapine greater than tiosperone greater than SCH23390 greater than fluperlapine greater than rilapine greater than chlorpromazine) had relatively high affinities (7-30 nM) for the cloned 5-HT1C receptor. Other antipsychotic agents (risperidone greater than tenilapine greater than mesoridazine greater than thioridazine greater than cis-fluphenthixol) had intermediate affinities (30-100 nM), whereas many other antipsychotics (fluphenazine greater than spiperone greater than amperozide greater than melperone greater than thiothixene greater than haloperidol, metoclopramide, pimozide, domperidone, sulpiride) had low affinities (greater than 500 nM) for the cloned 5-HT1C receptor. The results indicate that although several putative atypical antipsychotic agents have high affinities for the cloned rat 5-HT1C receptor, the spectrum of drug binding does not correlate with the atypical nature of these compounds.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347569

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  33 in total

1.  The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions?

Authors:  Marilyn A Davies; Beth Ann Compton-Toth; Sandra J Hufeisen; Herbert Y Meltzer; Bryan L Roth
Journal:  Psychopharmacology (Berl)       Date:  2004-10-13       Impact factor: 4.530

2.  Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs.

Authors:  Anil Purohit; Carol Smith; Katharine Herrick-Davis; Milt Teitler
Journal:  Psychopharmacology (Berl)       Date:  2004-12-10       Impact factor: 4.530

3.  The presynaptic component of the serotonergic system is required for clozapine's efficacy.

Authors:  Prem N Yadav; Atheir I Abbas; Martilias S Farrell; Vincent Setola; Noah Sciaky; Xi-Ping Huang; Wesley K Kroeze; LaTasha K Crawford; David A Piel; Michael J Keiser; John J Irwin; Brian K Shoichet; Evan S Deneris; Jay Gingrich; Sheryl G Beck; Bryan L Roth
Journal:  Neuropsychopharmacology       Date:  2010-11-03       Impact factor: 7.853

4.  Clozapine administration modifies neurotensin effect on synaptosomal membrane Na+, K+ -ATPase activity.

Authors:  María G López Ordieres; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

Review 5.  Mechanisms of action of atypical antipsychotic drugs: a critical analysis.

Authors:  B J Kinon; J A Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

6.  Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex.

Authors:  C Nocjar; K D Alex; A Sonneborn; A I Abbas; B L Roth; E A Pehek
Journal:  Neuroscience       Date:  2015-03-27       Impact factor: 3.590

7.  [3H]ketanserin binding in human brain postmortem.

Authors:  D Marazziti; A Rossi; L Palego; G Giannaccini; A Naccarato; A Lucacchini; G B Cassano
Journal:  Neurochem Res       Date:  1997-06       Impact factor: 3.996

8.  Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor.

Authors:  E P Pälvimäki; B L Roth; H Majasuo; A Laakso; M Kuoppamäki; E Syvälahti; J Hietala
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

Review 9.  Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs.

Authors:  Herbert Y Meltzer; Bryan L Roth
Journal:  J Clin Invest       Date:  2013-12-02       Impact factor: 14.808

10.  Molecular interactions between general anesthetics and the 5HT2B receptor.

Authors:  Felipe Matsunaga; Lu Gao; Xi-Ping Huang; Jeffery G Saven; Bryan L Roth; Renyu Liu
Journal:  J Biomol Struct Dyn       Date:  2013-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.